Search
Sumario de resultados
TIpos de contenido
Fecha
-
NewORYZON to give updates on corporate progress in January
6º Sachs Annual Neuroscience Innovation Forum 12º Annual LifeSci Advisors Corporate Access Event 41º Annual J.P. Morgan Healthcare Conference Invest Securities Biomed Forum 2023
-
NewPharmaMar leads the TERINMUN initiative, a research consortium in search of immunotherapie...
The project has been approved in the call for public-private collaboration projects of the Ministry of Science and Innovation, with 3.3 million euros in funding from the Recovery, Transformation and
-
CompanyAltum Sequencing
-
NewTransforming drug development with digital twins of the heart
Corify Care and GENESIS Biomed will develop a technology platform that uses non-invasive mapping, mathematical models of the heart and artificial intelligence to predict the side effects of treatments
-
-
-
New3P Biopharmaceuticals among the 500 fastest growing companies in Spain
This is the first year that the company appears in the ranking established by CEPYME
-
-
NewORYZON awarded EU grant to further explore the role of iadademstat in oncological immunoth...
Project will assess the efficacy of iadademstat in combination with checkpoint inhibitors and/or oncological vaccines
-
NewGENESIS Biomed continues growing and adding value in biomedical sector
Since it was established in May 2017, the company has worked on more than 253 consultancy projects, mobilised over €67.5 million, and managed 19 rounds of funding for clients, including two in 2022
-
NewBarcelona Science Park, a strategic hub for public R&D&i of excellence
2021 was a year full of challenges and milestones achieved for public research groups and institutes working at the Barcelona Science Park
-
Press releaseGroup of experts proposes actions to boost use of new technologies in biotechnology sector
AseBio and ASD present in Madrid the document with the main conclusions on the state of new technologies in the industry. One of the proposals for action is to train professionals and develop a
-
Press release
Las soluciones biotecnológicas se abren paso ante el desafío climático y energético
AseBio and FUNDECYT-PCTEx are holding the fifth edition of the Green Innovation Forum in Mérida, Extremadura. More than 300 experts from the Spanish biotechnology sector have gathered to promote a new
-
Press release
AseBio closes out year with 1,000 lines of research registered
86.6% of studies under way focus on improving people’s health and nearly 14% on protecting the planet. Of all these innovations, 203 are already available on the market or ready for exploitation Of
-
NewAseBio closes out year with 1,000 lines of research registered
86.6% of studies under way focus on improving people’s health and nearly 14% on protecting the planet. Of all these innovations, 203 are already available on the market or ready for exploitation
-
NewOxolife receives a 2.4M€ grant to develop a new treatment for infertility related to polyc...
Oxolife, in collaboration with Cordoba’s University, will advance from preclinical to phase II clinical trials in the next 2 years
-
NewORYZON presents final data from Phase IIa ALICE trial in unfit AML patients with first-lin...
Clinical efficacy signals were robust, with an objective response rate (ORR) of 81%; of these, 64% were complete remissions (14 CR/CRi) and 36% partial remissions (8 PR)
-
-
Offer
Investigador/a
-
-
